West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript February 12, 2026 West Pharmaceutical Services, Inc. misses on earnings expectations. Reported EPS is $1.82 EPS, ...

Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

Tariffs: Six Republicans joined nearly all Democrats on Wednesday in backing a resolution to rescind the tariffs President Trump imposed on Canada last year, a largely symbolic rebuke to the president ...

Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune ...

Today’s newsletter is about the Chinese government, a biolab, and reckless handling of dangerous pathogens. No, it’s not 2020.

SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S.

Shanghai-based Harbour BioMed’s acquisition of a stake in US-based Spruce Biosciences is the latest example of China’s novel drug developers progressing from one-time licensing deals into long-lasting ...

File on 4 Investigates whether the risks associated with the popular hair loss drug Finasteride are understood, after a 2024 review by UK drug safety regulator the MHRA prompted by a lack of awareness ...

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has hit the mark in two phase 3 trials and will be filed for approval as a potential first-in-class treatment for the disease.

A Trump administration official told The Hill and other outlets that the closure was a result of Mexican cartel drones ...